한글목차

전장 엑솜 시퀀싱 동향 및 전망

세계 전장 엑솜 시퀀싱 시장은 2024년부터 2030년까지 14.6%의 CAGR로 2030년까지 약 37억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 과학 및 기술 분야에서 시퀀싱의 응용 확대, 유전체 및 차세대 시퀀싱 기술의 지속적인 개발, 개인 맞춤형 의료에 대한 수요 증가입니다. 전 세계 전장 엑솜 시퀀싱 시장의 미래는 임상 진단, 신약 개발, 개인 맞춤형 의료 시장에서의 기회로 인해 유망합니다.

부문별 전장 엑솜 시퀀싱

이 조사에는 전 세계 전장 엑솜 시퀀싱의 제품별, 기술별, 용도별, 최종 용도별, 지역별 예측이 포함되어 있습니다.

전장 엑솜 시퀀싱 시장 인사이트

Lucintel은 예측 기간 동안 소모품이 가장 높은 성장세를 보일 것으로 예상하고 있습니다.

이 시장에서 신약 개발 및 시장 개척은 예측 기간 동안 가장 큰 부문으로 남을 것입니다.

북미는 예측 기간 동안 가장 큰 지역으로 남을 것입니다.

자주 묻는 질문

Q1. 시장 규모는?

A1. 세계 전장 엑솜 시퀀싱 시장은 2030년까지 약 37억 달러에 달할 것으로 예상됩니다.

Q2. 시장 성장 예측은?

A2. 세계 전장 엑솜 시퀀싱 시장은 2024년부터 2030년까지 연평균 14.6%의 성장률을 보일 것으로 예상됩니다.

Q3. 시장 성장에 영향을 미치는 주요 촉진요인은?

A3. 이 시장의 주요 촉진요인은 과학 기술에서 이 염기서열의 응용 확대, 유전체 및 차세대 염기서열 분석 기술의 지속적인 개발, 개인화 의료에 대한 수요 증가입니다.

Q4. 시장의 주요 부문은?

A4. 전장 엑솜 시퀀싱 시장의 미래는 임상 진단, 신약 개발, 개인 맞춤형 의료 시장에서의 기회로 인해 유망한 것으로 평가되고 있습니다.

Q5. 시장의 주요 기업은?

A5. 주요 전장 엑솜 시퀀싱 기업은 다음과 같습니다.

• Thermo Fisher Scientific
• Illumina
• Agilent Technologies
• BGI
• PacBio
• Oxford Nanopore Technologies
• Azenta
• CD Genomics
• Novogene
• Eurofins Genomics

Q6. 향후 가장 큰 시장 부문은?

A6. Lucintel은 소모품이 예측 기간 동안 가장 높은 성장을 이룰 것으로 예상합니다.

Q7. 시장에서 향후 5년간 가장 큰 시장이 될 것으로 예상되는 지역은?

A7. 북미는 예측 기간 동안 가장 큰 지역으로 남을 것입니다.

Q8. 보고서 사용자 정의가 가능합니까?

A8. 예, Lucintel은 추가 비용없이 10%의 사용자 정의를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 전장 엑솜 시퀀싱 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 전장 엑솜 시퀀싱 시장 동향(2018-2023년)과 예측(2024-2030년)
• 제품별 세계 전장 엑솜 시퀀싱 시장
  • 장비
  • 소모품
  • 서비스
• 기술별 세계 전장 엑솜 시퀀싱 시장
  • 합성에 의한 시퀀싱
  • ION 반도체 시퀀싱
  • 기타
• 용도별 세계 전장 엑솜 시퀀싱 시장
  • 임상 진단
  • 의약품 발견과 개발
  • 맞춤형 의료
  • 기타
• 최종 용도별 세계 전장 엑솜 시퀀싱 시장
  • 학술연구기관
  • 병원·클리닉
  • 제약·바이오테크놀러지 기업
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계 전장 엑솜 시퀀싱 시장
• 북미의 전장 엑솜 시퀀싱 시장
• 유럽의 전장 엑솜 시퀀싱 시장
• 아시아태평양의 전장 엑솜 시퀀싱 시장
• 기타 지역 전장 엑솜 시퀀싱 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 업무 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 제품별 세계 전장 엑솜 시퀀싱 시장 성장 기회
  • 기술별 세계 전장 엑솜 시퀀싱 시장 성장 기회
  • 용도별 세계 전장 엑솜 시퀀싱 시장 성장 기회
  • 최종 용도별 세계 전장 엑솜 시퀀싱 시장 성장 기회
  • 지역별 세계 전장 엑솜 시퀀싱 시장 성장 기회
• 세계의 전장 엑솜 시퀀싱 시장 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 전장 엑솜 시퀀싱 시장 능력 확대
  • 세계의 전장 엑솜 시퀀싱 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Thermo Fisher Scientific
• Illumina
• Agilent Technologies
• BGI
• PacBio
• Oxford Nanopore Technologies
• Azenta
• CD Genomics
• Novogene
• Eurofins Genomics

영문목차

Whole Exome Sequencing Trends and Forecast

The future of the global whole exome sequencing market looks promising with opportunities in the clinical diagnostic, drug discovery & development, and personalized medicine markets. The global whole exome sequencing market is expected to reach an estimated $3.7 billion by 2030 with a CAGR of 14.6% from 2024 to 2030. The major drivers for this market are growing application of this sequencing in science and technology, ongoing development in genomics and next-generation sequencing technologies, and rising demand for personalized medicine.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Whole Exome Sequencing by Segment

The study includes a forecast for the global whole exome sequencing by product, technology, application, end use, and region.

Whole Exome Sequencing Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Instruments
• Consumables
• Services

Whole Exome Sequencing Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Sequencing by Synthesis
• ION Semiconductor Sequencing
• Others

Whole Exome Sequencing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Clinical Diagnostics
• Drug Discovery & Development
• Personalized Medicines
• Others

Whole Exome Sequencing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Academic & Research Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Others

Whole Exome Sequencing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Whole Exome Sequencing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies whole exome sequencing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the whole exome sequencing companies profiled in this report include-

• Thermo Fisher Scientific
• Illumina
• Agilent Technologies
• BGI
• PacBio
• Oxford Nanopore Technologies
• Azenta
• CD Genomics
• Novogene
• Eurofins Genomics

Whole Exome Sequencing Market Insights

Lucintel forecasts that consumable is expected to witness the highest growth over the forecast period.

Within this market, drug discovery & development will remain the largest segment over the forecast period.

North America will remain the largest region over the forecast period.

Features of the Global Whole Exome Sequencing Market

Market Size Estimates: Whole exome sequencing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Whole exome sequencing market size by various segments, such as by product, technology, application, end use, and region in terms of value ($B).

Regional Analysis: Whole exome sequencing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, technologies, applications, end uses, and regions for the whole exome sequencing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the whole exome sequencing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the whole exome sequencing market size?

Answer: The global whole exome sequencing market is expected to reach an estimated $3.7 billion by 2030.

Q2. What is the growth forecast for whole exome sequencing market?

Answer: The global whole exome sequencing market is expected to grow with a CAGR of 14.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the whole exome sequencing market?

Answer: The major drivers for this market are growing application of this sequencing in science and technology, ongoing development in genomics and next-generation sequencing technologies, and rising demand for personalized medicine.

Q4. What are the major segments for whole exome sequencing market?

Answer: The future of the whole exome sequencing market looks promising with opportunities in the clinical diagnostic, drug discovery & development, and personalized medicine markets.

Q5. Who are the key whole exome sequencing market companies?

Answer: Some of the key whole exome sequencing companies are as follows:

• Thermo Fisher Scientific
• Illumina
• Agilent Technologies
• BGI
• PacBio
• Oxford Nanopore Technologies
• Azenta
• CD Genomics
• Novogene
• Eurofins Genomics

Q6. Which whole exome sequencing market segment will be the largest in future?

Answer: Lucintel forecasts that consumable is expected to witness the highest growth over the forecast period.

Q7. In whole exome sequencing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the whole exome sequencing market by product (instruments, consumables, and services), technology (sequencing by synthesis, ion semiconductor sequencing, and others), application (clinical diagnostics, drug discovery & development, personalized medicines, and others), end use (academic & research institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Whole Exome Sequencing Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Whole Exome Sequencing Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Whole Exome Sequencing Market by Product
  • 3.3.1: Instruments
  • 3.3.2: Consumables
  • 3.3.3: Services
• 3.4: Global Whole Exome Sequencing Market by Technology
  • 3.4.1: Sequencing by Synthesis
  • 3.4.2: ION Semiconductor Sequencing
  • 3.4.3: Others
• 3.5: Global Whole Exome Sequencing Market by Application
  • 3.5.1: Clinical Diagnostics
  • 3.5.2: Drug Discovery & Development
  • 3.5.3: Personalized Medicines
  • 3.5.4: Others
• 3.6: Global Whole Exome Sequencing Market by End Use
  • 3.6.1: Academic & Research Institutes
  • 3.6.2: Hospitals & Clinics
  • 3.6.3: Pharmaceutical & Biotechnology Companies
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Whole Exome Sequencing Market by Region
• 4.2: North American Whole Exome Sequencing Market
  • 4.2.1: North American Whole Exome Sequencing Market by Product: Instruments, Consumables, and Services
  • 4.2.2: North American Whole Exome Sequencing Market by Application: Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, and Others
• 4.3: European Whole Exome Sequencing Market
  • 4.3.1: European Whole Exome Sequencing Market by Product: Instruments, Consumables, and Services
  • 4.3.2: European Whole Exome Sequencing Market by Application: Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, and Others
• 4.4: APAC Whole Exome Sequencing Market
  • 4.4.1: APAC Whole Exome Sequencing Market by Product: Instruments, Consumables, and Services
  • 4.4.2: APAC Whole Exome Sequencing Market by Application: Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, and Others
• 4.5: ROW Whole Exome Sequencing Market
  • 4.5.1: ROW Whole Exome Sequencing Market by Product: Instruments, Consumables, and Services
  • 4.5.2: ROW Whole Exome Sequencing Market by Application: Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Whole Exome Sequencing Market by Product
  • 6.1.2: Growth Opportunities for the Global Whole Exome Sequencing Market by Technology
  • 6.1.3: Growth Opportunities for the Global Whole Exome Sequencing Market by Application
  • 6.1.4: Growth Opportunities for the Global Whole Exome Sequencing Market by End Use
  • 6.1.5: Growth Opportunities for the Global Whole Exome Sequencing Market by Region
• 6.2: Emerging Trends in the Global Whole Exome Sequencing Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Whole Exome Sequencing Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Whole Exome Sequencing Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: Illumina
• 7.3: Agilent Technologies
• 7.4: BGI
• 7.5: PacBio
• 7.6: Oxford Nanopore Technologies
• 7.7: Azenta
• 7.8: CD Genomics
• 7.9: Novogene
• 7.10: Eurofins Genomics